Merck & Co., Inc. Payments of Ordinary Dividends, Preferred Stock and Preference Stock
Merck & Co., Inc. (MRK) reported Payments of Ordinary Dividends, Preferred Stock and Preference Stock of $113.00 million for the 9-month period ending 2009-09-30, per its 10-Q filed 2009-10-29.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfDividendsPreferredStockAndPreferenceStock · last filed 2009-10-29
- Merck & Co., Inc. payments of ordinary dividends, preferred stock and preference stock for the quarter ending 2009-09-30 was $38.00M, a 0.00% change year-over-year.
- Merck & Co., Inc. payments of ordinary dividends, preferred stock and preference stock for the quarter ending 2008-09-30 was $38.00M.
| Period end | Payments of Ordinary Dividends, Preferred Stock and Preference Stock 3 month | Payments of Ordinary Dividends, Preferred Stock and Preference Stock 6 month | Payments of Ordinary Dividends, Preferred Stock and Preference Stock 9 month |
|---|---|---|---|
| 2009-09-30 | $38.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-10-29 | $113.00M 10-Q · filed 2009-10-29 | |
| 2009-06-30 | $75.00M 10-Q · filed 2009-07-24 | ||
| 2008-09-30 | $38.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-10-29 | $113.00M 10-Q · filed 2009-10-29 | |
| 2008-06-30 | $75.00M 10-Q · filed 2009-07-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |